3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
4
Phase NA
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Classical hematology
2
Plasma cell
1
Myeloid
1
Lymphoid
1
Conditions
Myelodysplastic Syndromes
382
Leukemia, Myeloid, Acute
356
Precursor Cell Lymphoblastic Leukemia-Lymphoma
184
Leukemia
149
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
147
Leukemia, Myelomonocytic, Chronic
128
Myeloproliferative Disorders
114
Leukemia, Lymphocytic, Chronic, B-Cell
100
Primary Myelofibrosis
99
Multiple Myeloma
89
Lymphoma, Non-Hodgkin
89
Hodgkin Disease
76
Blast Crisis
68
Lymphoma
62
Leukemia, Myeloid, Chronic-Phase
58
Lymphoma, Large B-Cell, Diffuse
53
Lymphoma, Mantle-Cell
52
Lymphoma, Follicular
52
Burkitt Lymphoma
52
Hematologic Neoplasms
51
Leukemia, Myeloid, Accelerated Phase
50
Congenital Abnormalities
47
Polycythemia Vera
45
Lymphoma, B-Cell, Marginal Zone
44
Thrombocythemia, Essential
43
Lymphoma, Large-Cell, Immunoblastic
43
Anemia, Refractory, with Excess of Blasts
42
Myelodysplastic-Myeloproliferative Diseases
41
Neoplasms, Plasma Cell
40
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
40
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Primary Immunodeficiency Diseases
×
Myeloid
×
Clear all
NCT03836690
2019-10-25
ToTem
University College, London
Phase 1
Unknown
18 enrolled